2014New England Journal of MedicineOpen access

Giant-Cell Arteritis and Polymyalgia Rheumatica

Cornelia M. Weyand, Jörg J. Goronzy

Open full text 407 citations

Abstract

Both giant-cell arteritis and polymyalgia rheumatica are immune-mediated diseases that are treated with glucocorticoids, with higher doses used for giant-cell arteritis. Prompt initiation of high doses and a biopsy are recommended when ischemic optic neuropathy is suspected.

About this research paper

What this paper is about

Both giant-cell arteritis and polymyalgia rheumatica are immune-mediated diseases that are treated with glucocorticoids, with higher doses used for giant-cell arteritis. Prompt initiation of high doses and a biopsy are recommended when ischemic optic neuropathy is suspected.

Why it matters

OpenAlex reports 407 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Both giant-cell arteritis and polymyalgia rheumatica are immune-mediated diseases that are treated with glucocorticoids, with higher doses used for giant-cell arteritis. Prompt initiation of high doses and a biopsy are recommended when ischemic optic neuropathy is suspected.

Key concepts: Polymyalgia rheumatica, Giant cell arteritis, Medicine, Arteritis, Biopsy, Dermatology, Optic neuropathy, Giant cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Giant-Cell Arteritis and Polymyalgia Rheumatica — Research Paper | ScholarLens